March 28th 2025
Fitusiran (Qfitlia) is approved for patients 12 years and older with or without factor VIII or IX inhibitors.
Community pharmacies preferred over mail order at a rate of 4:1, study shows
April 17th 2012When co-pays are similar, patients prefer community pharmacies versus mail order to fill their prescriptions by a ratio of 4 to 1, according to a new study published in the April 2012 issue of The Journal of Managed Care Pharmacy.
CPhA pushing bill to allow California pharmacists to perform OTC lab tests
April 17th 2012California pharmacists would be able to better assist patients with increasingly more complicated over-the-counter assessment tests if the state?s Senate approves new legislation, according to Jon Roth, CEO, California Pharmacists Association.
Kentucky law protects pharmacies against unfair PBM audit practices, NACDS says
April 17th 2012The recent passage of a Kentucky bill prohibiting pharmacy benefit managers from recouping payments through pharmacy audits when there is no evidence of fraud bodes well for similar federal legislation, according to a recent statement from the National Association of Chain Drug Stores.
Backlog of ANDAs could be alleviated with passage of generic drug user fee act
April 17th 2012Congressional approval of the bipartisan Generic Drug and Biosimilars User Fee Act could eliminate 90% of the backlog of Abbreviated New Drug Applications by 2017, FDA official Russell Wesdyk, BS, MBA, said in a presentation last month.
FDA approves first quadrivalent flu vaccine
April 17th 2012FDA approved the first 4-strain influenza vaccine live, intranasal (FluMist Quadrivalent, MedImmune) for the prevention of influenza. The vaccine?s 4 strains (2 type-A and 2 type-B lineages) help provide broad protection against circulating influenza A and B.
Risk of secondary cases of C. difficile in households doesn't justify interventions
April 5th 2012The risk of Clostridium difficile infection among households is too low to justify interventions, other than avoiding unnecessary antimicrobials, according to a new study, published in April?s Journal of Infection.